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Background: Indigenous Australian adults with diabetes continue to have suboptimal clinical control and poorer
outcomes compared with non-Indigenous people although there is a paucity of data documenting the detailed
health status of Indigenous people in Australia. To further investigate the characteristics of Indigenous Australian
adults with poorly controlled diabetes we analysed baseline data from a cluster randomized trial aiming to deliver a
program of integrated community-based intensive chronic disease management for Indigenous people in remote
communities in far north Queensland, Australia.
Methods: Indigenous adults aged 18 to 65 years from 12 clinics in rural north Queensland with established type 2
diabetes and with HbA1c ≥8.5% were invited to participate. The primary outcome variable measured at baseline
was HbA1c. Other variables measured included socio-demographic indicators, health literacy, BMI, blood pressure,
lipids, renal function, smoking status and quality of life measures. Data were collected between December 2010 and
July 2011. Analysis was performed by ethnicity – Aboriginal or Torres Strait Islander.
Results: One hundred and ninety three participants were included in the analysis. Very high rates of albuminuria,
high rates of smoking, dyslipidaemia, hypertension and elevated BMI were recorded. Aboriginal participants
reported higher levels of socio-economic disadvantage, higher smoking rates, lower BMI and worse self-reported
health status than Torres Strait Islander participants.
Conclusion: These results demonstrate a high potential for improved culturally sound community-based management
of diabetes and other comorbid conditions in this very high risk population. They also provide further evidence for
including albuminuria in cardiovascular risk calculation.
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Indigenous Australians experience very high prevalence,
morbidity and mortality from chronic health conditions
such as diabetes, cardiovascular, renal and chronic re-
spiratory disease [1-3]. The higher rates of these condi-
tions accounts for the majority of the ‘health gap’
between Indigenous and non-Indigenous Australian’s
with those residing in remote areas particularly affected
[4]. As a result, Indigenous people experience much* Correspondence: david.johnson@ahcsa.org.au
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unless otherwise stated.higher rates of avoidable hospital admissions from
chronic diseases [5,6] and, while the causes of this are
complex, a lack of access to effective primary health care
services is a major contributing factor [7].
Over recent years there has been an increasing focus
both internationally [8] and in Australia [9,10] on en-
hancing the capacity of primary care delivery systems,
originally set up to manage acute disease, to better pre-
vent and manage chronic diseases and their complica-
tions. The Chronic Care Model has been influential in
enhancing chronic illness care through improving clin-
ical system delivery design, clinical decision support,
clinical information systems, patient self-managementl. This is an Open Access article distributed under the terms of the Creative
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nity resources to better manage chronic disease [8].
At the same time, a number of Indigenous community
health services in Australia have undertaken chronic dis-
ease quality improvement initiatives adopting many of the
Chronic Care model components [11]. While improve-
ments have been made in the provision of routine clinical
care processes, there has been less success translating this
into improved intermediate clinical outcomes, such as gly-
caemic control for people with diabetes or reduction in
risk factors such as overweight and obesity [12,13]. This
has been in part attributed to what has been termed the
‘clinical inertia’ of treating doctors [14], particularly relat-
ing to delays in initiating insulin [15]. More importantly,
perhaps, has been the under-utilisation of the Indigenous
Health workforce. In Australia, there is good evidence that
Indigenous Health Workers (IHWs) are well placed to
provide routine chronic disease care via the use of disease
management protocols which is cost effective as long as
there is: (1) adequate training in chronic disease manage-
ment and health promotion/disease prevention; (2) good
clinical support mechanisms and; (3) system-level support
to ensure adequate staffing to enable chronic disease self-
management support for individuals, families and groups
in community settings [16-18].
Recognising the central role played by IHWs, the
“Getting Better at Chronic Care” (GBACC) study in
North Queensland is a randomized cluster trial that
aims to deliver integrated community-based, intensive
chronic disease management initially in a small number
of Indigenous communities in the Torres Strait, Cape
York and Cairns districts in far North Queensland,
Australia.
This paper reports on selected baseline clinical and so-
cioeconomic data from this study.
Methods
Study design, setting and participant selection
This is a baseline analysis of the GBACC study whose
methodology has been described elsewhere [19]. In sum-
mary, this is an open parallel randomised cluster trial de-
livering integrated community-based, intensive chronic
disease management, compared to usual care, via rural
and remote Indigenous primary health care services to In-
digenous Australians living in far North Queensland,
Australia. Twelve clinics (clusters) in rural north Queens-
land were chosen based on having significant Indigenous
populations and primary health care services provided
either by Queensland Health or a local community-
controlled Indigenous Health Service. Potential partici-
pants were identified from diabetic disease registers of the
participating health services. Adults aged 18 to 65 years
from these registers with established type 2 diabetes (diag-
nosed for more than one year) and with HbA1c ≥8.5%were invited to participate in the study. Written informed
consent was obtained from individual participants. Data
collection was undertaken between December 2010 and
July 2011.
Variables
The primary outcome variable measured at baseline
was HbA1c. Other variables measured included socio-
demographic indicators, health literacy, intermediate
clinical outcomes other than HbA1c (renal function,
blood pressure, lipids), preventative and patient self-
care practices and quality of life measures.
Ethnicity was based on self-report. Where participants
reported “both Torres Strait Islander and Aboriginal”
descent they were classified as Torres Strait Islander for
this analysis. Health literacy was measured using the
Test Of Functional Health Literacy in Adults (TOFHLA)
tool (score 0–100; 0–59 inadequate, 60–74 marginal,
75–100 adequate health literacy) [20]. Renal function
was calculated from serum creatinine using estimated
Glomerular Filtration Rate (eGFR) calculated by the
Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) formula [21] and albuminuria was defined as
a urinary albumin creatinine ratio (ACR) ≥2.5 mg/mmol
in men and ≥3.5 mg/mmol in women. Chronic kidney
disease (CKD) stage was calculated as per the Kidney
Health Australia Caring for Australasians with Renal Im-
pairment (KHA-CARI) guidelines [22]. Those with CKD
stage 4 and 5 were excluded from the study. Hypertension
was defined as blood pressure >140/90 or if prescribed an
antihypertensive medication. Dyslipidaemia was defined as
one or more of total cholesterol (TC) ≥4 mmol/L, high-
density lipoprotein cholesterol (HDL-C) <1 mmol/L and
triglyceride (TG) ≥1.5 mmol/L. Quality of life was mea-
sured using the Assessment of Quality of Life (AQoL) in-
strument and the 36-Item Short-Form (SF-36v2) health
survey. The TOFHLA tool, AQoL and SF-36v2 surveys as
well as a personal information survey were administered
face-to-face with participants. All clinical data was ob-
tained via review of hard copy primary health care charts,
patient information management systems (Ferret/Medical
Director/Best Practice as applicable) and Auslab/Auscare
databases for pathology.
Ethics approval
The GBACC study was approved by the University of
South Australia Human Research Ethics Committee, the
University of Queensland Medical Research Ethics Com-
mittee and the Cairns and Hinterland Health Service
District Human Research Ethics Committee with sup-
port from the relevant peak Aboriginal and Torres Strait
Islander Health Councils (Trial Registration number
12610000812099). This project has a high level of com-
munity engagement through partnering with the local
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ous health services and community councils of partici-
pating communities. The potential benefits of the study
are large both at the individual and family level as well
as for the Indigenous health workforce. Further, a major
strength of the project is its focus on sustainability
which will be achieved by building capability of the local
Indigenous health workforce.
Statistical analyses
Data were analysed by ethnicity as Torres Strait Islanders
are genetically, culturally and geographically distinct from
mainland Aboriginal Australians. We were interested in
exploring clinical as well as socio-demographic differences
between these populations which may have relevance to
diabetes/chronic disease management. Chi square tests
were used to compare proportions, student’s t-tests for
comparison of categorical and normally distributed con-
tinuous variables, Kruskal-Wallis tests for comparison of
categorical and non-normally distributed continuous vari-
ables and Spearman Rank correlation tests for comparison
of non-normally distributed continuous variables. Linear
regression was also performed to further assess associa-
tions. All analyses were undertaken using Stata version 11
(Stata Corp, TX, USA).
Results
One hundred and ninety three participants who met the
modified inclusion criteria were included in the baseline
data analysis. This represented approximately 75% of the
eligible population on registers who were invited to par-
ticipate. Equal numbers of Torres Strait Islander (n = 97)
and Aboriginal people (n = 96) were represented.
Socio-demographic characteristics for Aboriginal
and Torres Strait Islander participants
The mean age for participants was 48 years. Overall
there were a higher proportion of female participants
(64%) and this was most marked for Aboriginal people
(70%) (Table 1).
A high number of participants were not currently
employed (47%) although it was lower for Torres Strait Is-
landers (35%) than for Aboriginal people (59%) (p =
0.003). Aboriginal participants were also less likely to have
completed year 12 (p = <0.001), reported lower median in-
comes (p = <0.001), were more likely to not have enough
money for food at times (p < 0.001) and were more likely
to have missed meals in the previous fortnight (p < 0.001)
compared to Torres Strait Islanders (Table 1).
Despite this, there was little difference in median TO
FHLA scores by ethnicity but they were higher for those
who had completed year 12 (8.3, 95% CI, 2.6 to 13.9, p =
0.004) after controlling for age, sex and ethnicity.Overall the proportion of smokers was high (41%) with
Aboriginal people more likely to smoke (46%) compared
to Torres Strait Islanders (35%) (Table 1). Most of the
difference in smoking prevalence was accounted for by a
higher proportion of female Aboriginal smokers. Torres
Strait Islander mean body mass index (BMI) scores were
much higher than for Aboriginal people (BMI score 4.3,
95% CI, 1.8 to 6.7, p = 0.001) after controlling for smok-
ing, age and sex.Intermediate clinical outcomes and preventive care
practices
Even though only participants with HbA1c ≥8.5% were
included, median HbA1c overall was still very high
(10.9%) (Table 2). There was a weak association ob-
served between lower HbA1c and higher TOFHLA score
although this was unlikely to be clinically important (for
a 10 point increase in TOFHLA score HbA1c decreased
by 0.23%, 95% CI, −0.49 to +0.029%, p = 0.082).
A high proportion were diagnosed with hypertension
and, although overall mean systolic and diastolic read-
ings suggested reasonable blood pressure control, nearly
half of those with a diagnosis of hypertension recorded
blood pressure readings >140/90 .
The proportion of those with albuminuria was ex-
tremely high (75%) and the majority of participants were
classified as having stage 1 to stage 3 chronic kidney dis-
ease (73%) with CKD stage being slightly less advanced
for Aboriginal compared to Torres Strait Islander partic-
ipants. Overall, mean high-density lipoprotein choles-
terol (HDL-C) was low (0.98 mmol/L) with only 32% of
participants recording normal HDL levels. Mean total
cholesterol: HDL-C ratios were also high (5.3).
Forty per cent of participants were prescribed insulin
and 43% monitored their own blood sugars.
The majority of those with a diagnosis of hyperten-
sion were prescribed an anti-hypertensive medication
(92%) and relatively high proportions of those with both
albuminuria and dyslipidaemia were presribed renin-
angiotensin inhibitors (angiotensin converting enzyme in-
hibitors and/or angiotensin receptor blockers) (85%) and
lipid lowering medication (75%) respectively. Torres Strait
Islander participants were less likely to be adherent to all
medications (p = 0.02) (Table 2). Insulin use was not asso-
ciated with medication adherence.Selected quality of life and self-reported health measures
Although Aboriginal participants were less likely to be
anxious or depressed, they reported more pain and tired-
ness and they were less likely to report excellent or very
good health compared to Torres Strait Islanders (Table 3).
Table 1 Socio-demographic indicators by ethnicity, chronic care study, 2011 (N = 193†)
Aboriginal Torres Strait Islander Overall P-value
Number of participants 96 97 193
Mean (95% CI) age (years) 47.7 (45.9-49.6) 47.5 (45.5-49.5) 47.6 (46.2-49.0) 0.92
Number (%) of women 67 (70) 56 (58) 123 (64) 0.08
Employment status (%) 0.003
Full-time 25 (26) 41 (42) 66 (34)
Part-time 14 (15) 22 (23) 36 (19)
Unemployed 57 (59) 34 (35) 91 (47)
Education level attained (%) <0.001
Did not complete year 12 77 (80) 52 (54) 129 (67)
Year 12 certificate 2 (2) 16 (16) 18 (9)
TAFE course 14 (15) 19 (20) 33 (17)
University course 3 (3) 10 (10) 13 (7)
Median (interquartile range) income ($) 15080 (11960–27690) 28600 (14300–36400) 18980 (13000–33800) <0.001
Not enough money for food (%) 49 (51) 25 (26) 74 (38) <0.001
No. of missed meals past fortnight (%) <0.001
None 49 (55) 93 (98) 142 (77)
One to two 26 (29) 1 (1) 27 (15)
Three or more 14 (16) 1 (1) 15 (8)
Median (interquartile range) TOFHLA score 86.2 (72.5-94.0) 86.2 (68.8-91.1) 86.2 (71.1-93.0) 0.23
No. of people per house (interquartile range) 5 (3–7) 4 (3–7) 4 (3–7) 0.84
Smoking
Current smoking (%) 43 (46) 33 (35) 76 (41) 0.13‡
Never smoked (%) 33 (35) 37 (40) 70 (38)
Ex-smoker (%) 17 (18) 23 (25) 40 (21)
Current female smoker (%) 33 (50) 20 (36) 53 (44)
Current male smoker (%) 10 (37) 13 (34) 23 (35)
Mean (95% CI) body mass index (kg/m2) 30.3 (28.6-32.0) 34.2 (32.2-36.2) 31.9 (30.6-33.3) 0.004
†Missing data: Missed meals 9, Smoking 7, BMI 106.
‡Smoker/non-smoker as binary.
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This Indigenous population with poorly controlled dia-
betes recorded very high rates of albuminuria, a non-
traditional cardiovascular risk factor, as well as high rates
of smoking, elevated BMI, dyslipidaemia and hyperten-
sion. Differences related to ethnicity included higher levels
of socio-economic disadvantage, higher smoking rates,
lower BMI and worse self-reported health status for Abo-
riginal people compared to Torres Strait Islander people.
The prevalence of albuminuria (77%) was very high for
this group of Indigenous people. High rates of albumin-
uria have previously been reported in Indigenous popula-
tions in Australia with and without diabetes [23-26] most
pronounced in remote locations [27] and at much higher
levels than for non-Indigenous Australians [28,29]. In our
study, despite the higher prevalence of albuminuria, me-
dian eGFR was still relatively high although our results are
limited by the exclusion of those with CKD stage 4 and 5.Disproportionately high rates of albuminuria compared to
eGFR have previously been reported in Indigenous popu-
lations [26,29] which may reflect different age profiles and
rates of diabetic or obesity related hyper-filtration com-
pared to non-Indigenous populations. Albuminuria may
also be a better indicator of progression of CKD than
eGFR in those with type 2 diabetes or it may reflect differ-
ences in the origins and pathophysiology of CKD in Indi-
genous versus non-Indigenous populations [26,30]. For
our study eGFR was calculated using the CKD-EPI for-
mula which provides better estimates compared to the
MDRD formula [31].
There is good evidence that albuminuria independ-
ently predicts renal and cardiovascular risk in diabetics
[32,33] which is the leading cause of death for diabetics.
Albuminuria can be reduced through the use of renin-
angiotensin inhibitors [32,34]. In this Indigenous popula-
tion 85% of those with albuminuria were prescribed a
Table 2 Baseline intermediate clinical outcomes, chronic care study, 2011 (N = 193†)
Aboriginal Torres Strait Islander Overall P-value
Median (interquartile range) HbA1c 10.9 (9.6-12.1) 11.0 (9.7-12.4) 10.9 (9.7-12.2) 0.38
Hypertension diagnosed (%) 75 (78) 71 (74) 146 (76) 0.50
Mean (95% CI) systolic BP (mmHg) 131.0 (126.9-135.2) 131.6 (127.6-135.7) 131.3 (128.5-134.2) 0.84
Mean (95% CI) diastolic BP (mmHg) 80.0 (77.8-82.3) 78.8 (76.5-81.1) 79.4 (77.8-81.0) 0.44
Hypertension diagnosed and normal BP‡ (%) 38 (51) 39 (55) 77 (53) 0.61
Albuminuria (%) 56 (76) 47 (73) 103 (75) 0.76
Median (interquartile range) estimated glomerular
filtration rate (ml/min/1.73 m2)
103.9 (88.6-111.4) 94.7 (77.1-115.7) 100.6 (80.9-113.0) 0.27
Chronic kidney disease stage 0.08
Normal renal function 17 (24) 19 (29) 36 (27)
Stage 1 (%) 35 (49) 21 (32) 56 (41)
Stage 2 (%) 15 (21) 14 (22) 29 (21)
Stage 3 (%) 4 (6) 11 (17) 15 (11)
Total 71 65 136
Mean (95% CI) total cholesterol (mmol/L) 4.7 (4.4-5.0) 4.6 (4.3-4.9) 4.6 (4.4-4.8) 0.53
Total cholesterol <4 mmol/L (%) 25 (31) 27 (38) 52 (34) 0.38
Mean (95% CI) high-density lipoprotein cholesterol (mmol/L) 0.90 (0.85-0.95) 1.05 (0.77-1.3) 0.98 (0.83-1.12) 0.32
High-density lipoprotein cholesterol ≥1 mmol/L (%) 25 (38) 18 (26) 43 (32) 0.13
Mean total cholesterol: HDL ratio (95% CI) 5.3 (4.9-5.7) 5.3 (4.9-5.7) 5.3 (5.0-5.6) 0.88
Median (interquartile range) triglyceride (mmol/L) 2.2 (1.5-3.5) 1.7 (1.1-2.8) 2.0 (1.2-3.1) 0.02
Triglyceride <1.5 mmol/L (%) 19 (24) 33 (46) 52 (35) 0.004
Dyslipidaemia (%) 78 (98) 66 (93) 144 (95) 0.19
Taking insulin (%) 35 (36) 43 (44) 78 (40) 0.27
Monitors own blood sugar (%) 45 (47) 37 (39) 82 (43) 0.22
Adherent to all medications (%) 46 (48) 31 (32) 77 (40) 0.02
Prescribed anti-hypertensive medication if diagnosis of hypertension (%) 67 (89) 67 (94) 134 (92) 0.27
Albuminuria and prescribed renin-angiotensin inhibitors (%) 45 (80) 42 (89) 87 (85) 0.13
Prescribed lipid lowering medication (%) 77 (80) 68 (70) 145 (75) 0.10
†Missing data: Systolic and Diastolic BP 9, Hypertension diagnosed 1, Albuminuria 55, CKD 54 (3 CKD stage 4 not included), TC 42, HDL-C 59, TG 43, Dyslipidaemia
42, monitors blood sugar 2, sometimes miss medication 9.
‡Defined as <140/90.
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of renin-angiotensin blockade in an urban sample of
both Indigenous Australians with diabetes (47%) and
non-Indigenous Australians with diabetes (66%) [29].
However, it may be that despite the appropriate drugs
being prescribed, the dose titration may not be adequate
to impact most effectively for renal protection.
Only 40% of Indigenous participants were prescribed in-
sulin despite the high glycaemic levels. This may still re-
flect a degree of clinical inertia [35] on the part of medical
staff working with Indigenous clients, as they are not be-
ing treated as intensively as clinically indicated.
Although previous studies have shown inadequate
health literacy is associated with worse glycaemic control
[36,37], there was little evidence for such a relationship
for Indigenous participants in our study. It may be thatthere was not the diversity of HbA1c measures to show
such a relationship given that only people with uncon-
trolled diabetes were included. It was also interesting to
note that despite the relative socioeconomic disadvantage,
including lower year 12 completion rates, Aboriginal people
had similar health literacy scores to Torres Strait Islanders.
This suggests either limitations with the TOFHLA tool
used in this setting or that other unmeasured factors were
compensating for this disadvantage.
Women were over-represented in the Indigenous sam-
ple of people with uncontrolled diabetes. This has previ-
ously been shown in both remote and urban Indigenous
Australian populations [38] as a result of higher rates of
obesity in Indigenous women placing them at higher risk
of diabetes [39]. This is in contrast to non-Indigenous
populations where women and men are either equally
Table 3 Quality of life measures by ethnicity, chronic care study, 2011 (N = 193)
Aboriginal Torres Strait Islander Overall P-value
Anxious or depressed <0.001
No 37 (39) 18 (19) 55 (29)
Slightly 47 (49) 75 (77) 122 (63)
Moderately 12 (12) 4 (4) 16 (8)
Pain 0.01
None 58 (60) 79 (81) 137 (71)
Moderate 31 (32) 15 (16) 46 (24)
Severe 5 (5) 3 (3) 8 (4)
Unbearable 2 (2) 0 2 (1)
Self-reported health status 0.008
Excellent or very good 12 (13) 30 (31) 42 (22)
Good 50 (52) 41 (42) 91 (47)
Fair or poor 34 (35) 26 (27) 60 (31)
Tired <0.001
All or most of the time 20 (21) 6 (6) 26 (13)
Some of the time 50 (52) 38 (39) 88 (46)
A little or none of the time 26 (27) 53 (55) 79 (41)
Anxious or depressed Q14 from the Assessment of Quality of Life Survey (AQoL); pain Q15 from AQoL survey; self-reported health status Q1 from SF-36v2 Health
Survey; tired Q9i from SF-36v2.
Johnson et al. BMC Public Health  (2015) 15:325 Page 6 of 8represented [29,38] or men over-represented [40]. In our
sample, BMI was significantly lower for Aboriginal com-
pared to Torres Strait Islander participants and this per-
sisted after controlling for age, smoking status and sex.
Such differences have previously been reported [28] and
may be explained by a greater relative lean body mass
for given height for Torres Strait Islanders given their
genetically Melanesian origins [41,42]. Relative food in-
security as a result of relative socio-economic disadvan-
tage for Aboriginal participants may also explain some
of this difference in our study.
The mean age of people in our sample was very young.
It has previously been shown that Indigenous Australians
are diagnosed with diabetes at a much younger age than
non-Indigenous Australians [28,29]. Possible explanations
include a survival bias whereby Indigenous populations
experience more risk factors (such as obesity and smok-
ing) for diabetes and diabetes related complications result-
ing in higher mortality rates in the middle age years [3] as
well as environmental influences in early life such as poor
intrauterine growth [43] leading to earlier and more pro-
gressive disease.
There were limitations to this study. Indigenous par-
ticipants were recruited from communities who in turn
were selected based on the likelihood that their health
service had the capacity and the organizational support
to deliver the intervention and so results may not be
generalizable to all Aboriginal and Torres Strait Islander
communities. Although interesting, our results related tohealth literacy should be treated with caution. Current as-
sessment tools, including the TOFHLA survey, essentially
measure reading skills and may not differentiate between
reading ability and background knowledge of scientific
health concepts and/or cultural differences in the under-
standing of health and health care [44]. Further, given that
only people with diabetes and HbA1c levels ≥8.5% were
included, the results may not be generalizable to all Indi-
genous Australians with diabetes. For some clinical vari-
ables there were missing data although the characteristics
of participants with missing data were similar to those
with data recorded. This pragmatic trial in a highly mobile
population reflects the realities of delivering optimal dia-
betes care. Prevalence of albuminuria may be overesti-
mated as urinary ACR calculations were based on a single
sample and microscopy, culture and sensitivity was not
performed at the time of collection.
Effective and sustained delivery of diabetes care by
Indigenous Health Workers who are linguistically and
culturally close to their clients has previously been
demonstrated in the Torres Strait [12,16,45]. This re-
sulted in much improved continuity of care compared
to that provided by an itinerant and often inexperi-
enced non-Indigenous workforce. It is our view that
better utilisation of the Indigenous health workforce
has the potential to increase the health standards in
high need populations through the delivery of more
culturally safe health care and greater engagement with
the extended family of people living with diabetes.
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As such, these results demonstrate a high potential for
improved culturally-sound integrated community-based
management of diabetes and other comorbid conditions
in this very high risk population. They also provide fur-
ther evidence for including albuminuria in cardiovascu-
lar risk calculation in clinical settings in addition to
traditional risk factors [46].
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